dabigatran has been researched along with Adenocarcinoma in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Hu, MH; Wang, V; Wu, BC | 1 |
Goodrich, ST; Patel, SA | 1 |
Beyer-Westendorf, J; Folprecht, G; Weiss, N; Werth, S | 1 |
Finsterer, J; Rakusan, S; Stöllberger, C; Wimpissinger, FT | 1 |
4 other study(ies) available for dabigatran and Adenocarcinoma
Article | Year |
---|---|
The resolution of carotid arterial thrombus by oral anticoagulation after IV thrombolysis for chemotherapy-induced stroke: A case report.
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Antithrombins; Carotid Artery Thrombosis; Carotid Artery, Internal; Dabigatran; Female; Humans; Infarction, Middle Cerebral Artery; Magnetic Resonance Angiography; Middle Aged; Plaque, Atherosclerotic; Sigmoid Neoplasms; Thrombolytic Therapy; Tissue Plasminogen Activator | 2020 |
Endometrial adenocarcinoma following supracervical hysterectomy managed with radiation due to dabigatran etexilate.
Topics: Adenocarcinoma; Aged; Benzimidazoles; Dabigatran; Endometrial Neoplasms; Factor Xa Inhibitors; Female; Follow-Up Studies; Humans; Hysterectomy; Positron-Emission Tomography; Pyridines; Radiotherapy, Conformal; Tomography, X-Ray Computed; Uterine Hemorrhage | 2014 |
Trousseau's syndrome in a patient with adenocarcinoma of unknown primary and therapy-resistant venous thrombosis treated with dabigatran and fondaparinux.
Topics: Adenocarcinoma; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Drug Resistance; Drug Therapy, Combination; Female; Fondaparinux; Humans; Middle Aged; Neoplasms, Unknown Primary; Polysaccharides; Syndrome; Treatment Outcome; Venous Thrombosis | 2011 |
Spontaneous gross haematuria during dabigatran therapy for secondary stroke prevention.
Topics: Adenocarcinoma; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Bone Neoplasms; Brain Ischemia; Comorbidity; Dabigatran; Hematuria; Humans; Kidney Failure, Chronic; Leuprolide; Male; Prostatic Neoplasms; Pulmonary Disease, Chronic Obstructive; Secondary Prevention; Thrombophilia; Urinary Retention | 2012 |